GRN and lymphoma: Some patients with breast, lung, prostate, and ovarian cancer, glioblastoma, chronic lymphocytic leukemia, and malignant lymphoma have elevated serum progranulin level, which is associated with decreased overall survival, disease-free survival, relapse-free survival, and progression-free survival [10, 11, 12, 13, 14, 15,16, 17].